Cargando…
Multicomponent vaccines to fight SARS-CoV-2 variants of concern
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557988/ https://www.ncbi.nlm.nih.gov/pubmed/34743927 http://dx.doi.org/10.1016/j.vaccine.2021.10.069 |
_version_ | 1784592469066776576 |
---|---|
author | Cassone, Antonio Cauda, Roberto |
author_facet | Cassone, Antonio Cauda, Roberto |
author_sort | Cassone, Antonio |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8557988 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85579882021-11-01 Multicomponent vaccines to fight SARS-CoV-2 variants of concern Cassone, Antonio Cauda, Roberto Vaccine Commentary Elsevier Ltd. 2021-11-26 2021-11-01 /pmc/articles/PMC8557988/ /pubmed/34743927 http://dx.doi.org/10.1016/j.vaccine.2021.10.069 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Commentary Cassone, Antonio Cauda, Roberto Multicomponent vaccines to fight SARS-CoV-2 variants of concern |
title | Multicomponent vaccines to fight SARS-CoV-2 variants of concern |
title_full | Multicomponent vaccines to fight SARS-CoV-2 variants of concern |
title_fullStr | Multicomponent vaccines to fight SARS-CoV-2 variants of concern |
title_full_unstemmed | Multicomponent vaccines to fight SARS-CoV-2 variants of concern |
title_short | Multicomponent vaccines to fight SARS-CoV-2 variants of concern |
title_sort | multicomponent vaccines to fight sars-cov-2 variants of concern |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557988/ https://www.ncbi.nlm.nih.gov/pubmed/34743927 http://dx.doi.org/10.1016/j.vaccine.2021.10.069 |
work_keys_str_mv | AT cassoneantonio multicomponentvaccinestofightsarscov2variantsofconcern AT caudaroberto multicomponentvaccinestofightsarscov2variantsofconcern |